In line with this, specific targeting of KLC2 was able to completely rescue the proliferative effect induced by LINC00152 overexpression in vitro, suggesting the LINC00152-miR-143-KLC2 axis as a new potential therapeutic target in human HCC. The gene discussed is KLC2; the disease is hepatocellular carcinoma.